Dacula, Sittie Alisha A.
HRN: 21-57-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
AMPICILLIN 250MG (VIAL)
08/19/2022
08/26/2022
IVTT
150mg
Q12h
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes